Senior insider sale
Exec. VP and CLO at PTC THERAPEUTICS, INC. — senior position signals high conviction
$1.58M
20.86K shares
What this filing means
BOULDING MARK ELLIOTT plans to sell 20.86K shares of PTC THERAPEUTICS, INC. valued at approximately $1.58M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/17/2026ACC: 0001959173-26-001030
Officer· Exec. VP and CLO
Since Jan 2019
20.86K
Shares to sell
$1.58M
Approx. market value
2.81K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Option Granted 02/15/2024
Cash
2/17/2026
2.81KTotal acquired2.81K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/17/2026 | Option Granted 02/15/2024 Cash | 2.81K | — |
| Total | 2.81K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
2.31K
Market value
$180.3K
1/9/2026
—Completed
Units to sell
4.03K
Market value
$308.8K
1/8/2026
—Completed
Units to sell
4.88K
Market value
$377.8K
1/7/2026
—Completed
Units to sell
1.74K
Market value
$133.8K
1/6/2026
—Completed
Units to sell
2.27K
Market value
$171.2K
1/5/2026
—Completed
Units to sell
2.81K
Market value
$213.7K
11/17/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.81K
Market value
$194.5K
2/17/2026
Total
Units
20.86K
Value
$1.58M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/9/2026 | 2.31K | $180.3K | — | Completed |
1/8/2026 | 4.03K | $308.8K | — | Completed |
1/7/2026 | 4.88K | $377.8K | — | Completed |
1/6/2026 | 1.74K | $133.8K | — | Completed |
1/5/2026 | 2.27K | $171.2K | — | Completed |
11/17/2025 | 2.81K | $213.7K | — | Completed |
| Planned — Approximate Date | ||||
2/17/2026 | 2.81K | $194.5K | NASDAQ | Planned |
| Total | 20.86K | $1.58M | ||